Evidence map›Paper›PMID 33445491›Full record

ReviewInternational journal of molecular sciences2021

Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis.

Andy W C Man, Huige Li, Ning Xia

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andy W C ManDepartment of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany.ORCID 0000-0002-4113-6479
Huige LiDepartment of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany.ORCID 0000-0003-3458-7391
Ning XiaDepartment of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany.ORCID 0000-0002-5553-1752
Johannes Gutenberg University Mainz · DE

Funding

Deutsche Forschungsgemeinschaft LI-1042/1-1, LI-1042/3-1, LI-1042/5-1, and XI 139/2-1
6 · The paper itself

Abstract

Every organism has an intrinsic biological rhythm that orchestrates biological processes in adjusting to daily environmental changes. Circadian rhythms are maintained by networks of molecular clocks throughout the core and peripheral tissues, including immune cells, blood vessels, and perivascular adipose tissues. Recent findings have suggested strong correlations between the circadian clock and cardiovascular diseases. Desynchronization between the circadian rhythm and body metabolism contributes to the development of cardiovascular diseases including arteriosclerosis and thrombosis. Circadian rhythms are involved in controlling inflammatory processes and metabolisms, which can influence the pathology of arteriosclerosis and thrombosis. Circadian clock genes are critical in maintaining the robust relationship between diurnal variation and the cardiovascular system. The circadian machinery in the vascular system may be a novel therapeutic target for the prevention and treatment of cardiovascular diseases. The research on circadian rhythms in cardiovascular diseases is still progressing. In this review, we briefly summarize recent studies on circadian rhythms and cardiovascular homeostasis, focusing on the circadian control of inflammatory processes and metabolisms. Based on the recent findings, we discuss the potential target molecules for future therapeutic strategies against cardiovascular diseases by targeting the circadian clock.

Indexed as

Circadian RhythmAnimalsAtherosclerosisBiomarkersCircadian ClocksDisease ManagementDisease SusceptibilityGene Expression RegulationHomeostasisHumansMolecular Targeted TherapyThrombosisVascular DiseasesBiomarkerscardiovascular diseasescircadian disruptionclock genesinflammationoxidative stress

Identifiers

PMID33445491
PMCPMC7827891
OpenAlexW3118595062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.